BloomWell Rx review
Wellness priced, entity unclear
A fully online service publishing monthly starting prices for sermorelin, NAD⁺ and glutathione — from a site whose medical entity is not clearly named.
Our verdict
BloomWell Rx puts a monthly starting price on each wellness product, states in its own words that its medication is compounded by a third-party pharmacy it does not own, and posts a complete legal suite. That is three things most of this batch skips. The unresolved question is who you are actually buying from: the site is operated by a marketing agency, the medical entity is not clearly named, and the pharmacy is not named either.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.
At a glance
- Category
- Peptide telehealth
- Access
- NAD⁺ from $249/mo, free initial visit; state list not published
- Insurance
- Cash-pay, no insurance
- Visit
- Async intake
- Updated
- July 2026
Popular alternative
Oak Longevity
Low-cost sermorelin within a broader longevity stack
Check Oak Longevity availability →What it is
BloomWell Rx is a 100% online telehealth service split into two verticals: compounded GLP-1 weight loss, and a wellness line of NAD⁺, sermorelin and glutathione. Each product carries a published "starts at" monthly price. Treatment begins with a free visit, and its own personalized-GLP-1 page states verbatim that medication is compounded and dispensed by a licensed third-party pharmacy and that BloomWell Rx is neither a state-licensed pharmacy nor a drug manufacturer. It publishes Terms, Privacy, HIPAA and refund policies.
How it works
A free initial visit, an online review, then medication shipped, with a patient portal and flexible dosing advertised. The disclosure that BloomWell is not itself a pharmacy or manufacturer is the sort of thing a buyer should want stated explicitly, and here it is, on the treatment page rather than buried. The full legal suite — Terms, Privacy, HIPAA notice, returns and refunds — is a genuine point of difference in a batch where several competitors publish none of it. Against that sits an identity problem. The footer credits the site as built and operated by a marketing agency, the operating medical entity is not clearly named, and the licensed third-party pharmacy is never identified. No state list is published, so coverage is confirmed at intake, and there is no baseline lab work before a growth-hormone-axis peptide.
Pricing transparency
BloomWell publishes a monthly starting price for each wellness product: sermorelin from $349/mo, which is the figure on our board, with NAD⁺ and glutathione from $249/mo each. Its GLP-1 line is priced publicly too. Publishing the peptide number rather than the weight-loss number alone is what earns it a place here — most competitors price the GLP-1 side and leave the peptide side blank. Every figure is a "starts at", so the final cost depends on dose and plan; establish what dose $349 supplies, what a titrated protocol costs, and what refills look like. Sermorelin at this level is at the higher end of the published prices on this board, which is worth weighing against what you can verify about who is supplying it.
Branded vs compounded
Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. BloomWell states this itself: its medication is compounded and dispensed by a licensed third-party pharmacy, and it is not a pharmacy or a manufacturer — clear language, undercut by the fact that the pharmacy is never named, which matters because compounded sterile products are not FDA-reviewed for purity and potency the way approved drugs are. On the evidence, the wellness line splits three ways. Sermorelin acts on the growth-hormone axis, a real and well-described mechanism, with thin long-term human outcome data and no controlled trial supporting the anti-aging or body-composition framing. Injectable NAD⁺ has no controlled human outcome trials at all; the oral precursors NR and NMN are the studied forms, and they raise blood NAD⁺ — a biomarker, not a demonstrated outcome. Injectable glutathione has essentially no controlled human outcome evidence for the claims made about it. The site also carries a brand-disclaimer footer noting it does not supply the branded GLP-1 drugs whose trademarks it references, which is the correct disclosure to make. Individual results vary.
Pros and watch-outs
What we like
- Monthly starting prices published for sermorelin, NAD⁺ and glutathione, not just the GLP-1 line
- States on its own treatment page that it is not a pharmacy or a drug manufacturer
- Full legal suite published: Terms, Privacy, HIPAA notice, returns and refunds
- Free initial visit with a fully online process and a patient portal
- Brand-disclaimer footer correctly separates it from the branded GLP-1 manufacturers
Watch-outs
- The operating medical entity is not clearly named, and the site is run by a marketing agency
- The licensed third-party pharmacy is never identified
- No LegitScript certification displayed
- No state list published — coverage is only confirmed at intake
- Sermorelin at $349/mo sits at the higher end of the published prices on this board
Best for
People who want to see a sermorelin price before starting an intake, from a service that publishes its legal policies and admits what it is not.
Who should look elsewhere
Anyone who needs to know which company and which pharmacy stand behind the prescription, or who is shopping on price alone.
The evidence behind what BloomWell Rx prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- Sermorelin: a real GHRH drug, read against the anti-aging pitch
An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
- Glutathione: the master antioxidant, and where the evidence actually is
Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.
How BloomWell Rx compares
A few alternatives worth a look, depending on what you’re optimizing for.
Telos RXChoice of GLP-1 formats, including needle-free sublingual tirzepatide
See Telos RX →- Luvo Health
Prescription NAD⁺ as an injection, drops or nasal spray at one flat price
See Luvo Health →
Invigor MedicalPrescription at-home NAD⁺ injections via telehealth
See Invigor Medical →
Research & data · Reviewed and last verified July 2026
How we assessed this. This review reflects Aminoscope’s own read of BloomWell Rx’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- What does BloomWell Rx charge for its wellness line?
- It publishes sermorelin from $349 per month, with NAD⁺ and glutathione from $249 per month each, alongside published GLP-1 pricing. All are "starts at" figures, so confirm what dose that supplies and what a titrated protocol costs.
- Who actually operates BloomWell Rx?
- That is the unresolved question. The footer credits the site as built and operated by a marketing agency, the operating medical entity is not clearly named, and the compounding pharmacy is described only as a licensed third-party pharmacy. Ask which company holds the medical practice and which pharmacy fills your order.
- Is it a good sign that BloomWell says it is not a pharmacy?
- Yes. Stating plainly that it is neither a state-licensed pharmacy nor a drug manufacturer tells you where responsibility sits, and it appears on the treatment page rather than buried in the terms. It would be a much stronger disclosure if the pharmacy that is responsible were named.
- Does sermorelin justify $349 a month?
- That is a judgement about price, not evidence. On evidence, sermorelin's growth-hormone-axis mechanism is real and well described, but no controlled human trial shows compounded sermorelin delivers the body-composition or anti-aging results it is marketed for, and the long-term data stays thin. Other providers on this board publish lower sermorelin figures.